Search results - 16 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
a monthly basis, using a study period covering an eight-week follow-up period. Each month the study period was shifted forward to the following month. Country estimates were then pooled together. The study ...
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign)
a subsequent (third) booster during this new campaign, with a minimum interval of 3 months between the 2 doses. As such, this autumn campaign included mainly administrations of second, but also third ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
3 months (but more than 2 weeks ago), the prevalence of anti- SARS-CoV-2 antibodies was 97.9% in the first period of wave 2 (27/09-24/10) and 99.1% in the second period (25/10-21/11). Among the fully ...
Excess mortality during the first and second waves of the COVID-19 epidemic in Belgium
analysis encompassing entire winter seasons is more accurate for flu, which often spreads over several winter months, spread over two calendar years. It provides very different results than a typical annual ...
Annual Report Belgian Cystic Fibrosis Registry 2018
in 2018, among them five adults, with a median age at diagnosis of 9.8 months and age range from birth to 70.6 years. All the newly diagnosed patients were genotyped; 18 had sweat chloride values > ...
Annual Report Belgian Cystic Fibrosis Registry 2017
diagnosis. There were 38 newly diagnosed patients in 2017, among them two adults, with a median age at diagnosis of 5.4 months with a range from birth to 60.4 years. All the newly diagnosed patients were ...
Annual report Belgian Cystic Fibrosis Registry 2016
fifteen without a confirmed diagnosis. There were 23 newly diagnosed patients in 2016, among them three adults, with a median age at diagnosis of 3.8 months with a range from birth to 52.3 years. All the ...
Initiative for Quality Improvement and Epidemiology in Multidisciplinary Diabetic Foot Clinics (IQED-Foot)- Results of the 4th data collection (audit years 2013-2014)
intake and the treatment and outcomes over the course of 6-12 months. After the audit, centres received a feedback report including benchmarking of their performance with regard to a number of ...
Epidemiologie en behandeling van acute Charcot voet: prospectieve follow-up studie van 62 patiënten uit de IKED-Voet studie
patients presenting with diabetic foot problems, resulting in a total of 1782 cases in 2014. 62 cases were registered as acute Charcot foot and followed up to a maximum of seven months in terms of treatment ...
Role of wildlife and domestic pigs as reservoirs for hepatitis E virus (HEV): study of the infection in suids and cervids and of the susceptibility of pigs to HEV originating from wild boa
2011. In total, 420 serum samples of fattening pigs aged less than 6 months were used for virological studies and 420 serum samples of lactating sows for serological testing. The presence of HEV-specific ...